Antimicrobial Stewardship: Improving Clinical Outcomes by Optimization of Antibiotic Practices

Monday, April 16, 2018, 12:00 AM - Friday, April 16, 2021, 12:00 AM PST

Internet Enduring Material Jointly Provided by Stanford University School of Medicine (CME) and University of Rhode Island College of Pharmacy. Presented by the Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. Sponsored by the Stanford University School of Medicine.

Antibiotics are among the most frequently prescribed classes of drugs and it is estimated that approximately 50% of antibiotic use, in both the outpatient and inpatient settings, is inappropriate. At the same time, in contrast to any other class of drugs, every antibiotic use has a potential public health consequence – inappropriate use may not harm only the individual patient, but contributes to societal harm by exerting an unnecessary selective pressure that may lead to antibiotic resistance among bacteria. This video based course will introduce learners to the basic principles of appropriate antibiotic use, demonstrate how to apply these principles to the management of common infections, and outline how to develop and maintain an antimicrobial stewardship program. We will offer a number of illustrative cases, recognizable to the practicing physician in his or her practice to engage learners in the thought processes that lead to optimal decision making, improved outcomes of individual patients, and harm reduction vis-a-vis the bacterial ecology. The course will also explore strategies to implement principles of antimicrobial stewardship both in your practice and also at a program level.

Intended Audience

This course will offer a practical approach to prescribing antibiotic therapy and development of antimicrobial stewardship to physicians and pharmacists across all specialties and settings.

• Release Date: April 16, 2018
• Expiration Date: April 16, 2021
• Estimated Time to Complete: 7.00 hours
• CME Credits Offered: 7.00
• ACPE Credits: 7.0 contact hours (0.70 ceus)
• Registration Fee: FREE

Pharmacists wishing to claim ACPE credit must use the procedure outlined below:
Review the information below and complete the entire activity. Complete the Post-test and Evaluation Survey. You must receive a score of 75% or higher on the post-test in order to pass. You will have two attempts to answer each multiple-choice question (or one attempt for questions with only two options) to pass the post-test.

All participants will have the opportunity to evaluate the educational session and speaker and to identify future educational needs.

A program evaluation must be completed at www.uripharmacycpd.org within 60 days of completing the program in order to receive CE credit.  CE credit will be transferred to the CPE Monitor upon successful completion of the program evaluation. Transfer of CE credit should be verified at mycpemonitor.net where CE statements are available to print. Please refer to the evaluation instructions that follow for completing program evaluations and reporting CE credit.

After you successfully complete the activity, you should email cmeonline@stanford.edu for an activity link to the URI Continuing Professional Development (CPD) Management System at: www.uripharmacycpd.org to complete a program evaluation, claim your ACPE credit, and report your CE participation in the activity.

AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Participation Credit (7.00 hours)

1. Apply IDSA guidelines in treating infections such as acute rhino-sinusitis, cystitis and acute bronchitis.
2. Incorporate guidelines/standardized protocols to diagnose and prescribe antibiotic therapy for treating sepsis.
3. Develop strategies to implement evidence based practices for antimicrobial stewardship in your practice setting.
4. Develop a plan to lead an antimicrobial stewardship program.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Stanford University School of Medicine designates this enduring material for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME. Please check with your state’s credentialing board for their requirements.

The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity. Pharmacists will receive 7.0 contact hours (0.70 ceus) for the educational activity. No partial credit is available. Universal Activity Number (UAN): 0060-9999-18-054-H01-P

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Bibliography
CDC. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/

BarlamTF, Cosgrove SE, AbboLM, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. ClinInfect Dis. 2016; 62:e51-77

CDC. Core Elements of Hospital Antibiotic Stewardship Programs. http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html

For a complete list, please view the References/Bibliography page of the Course 

Disclosures

The following planners, speakers, and reviewers have indicated that they have no relationships with industry to disclose relative to the content of this activity.

• Stan Deresinski, MD, FIDSA 
  Clinical Professor of Infectious Diseases
  Director of Antimicrobial Stewardship Program
  Stanford University School of Medicine
  Course Director
  Speaker
  
• Marisa Holubar, MD, MS
  Clinical Assistant Professor of Infectious Diseases
  Associate Director of Stanford Antimicrobial Safety and Sustainability Program
  Stanford University School of Medicine
  Course Director
  Speaker
  Reviewer
  
• Emily Mui, PharmD, BCPS
  Infectious Disease Pharmacist, Antimicrobial Stewardship Program
  Stanford University School of Medicine
  Course Director
  Speaker
  
• Elizabeth Robilotti, MD, MPH
  Associate Director, Infection Control Program
  Memorial Sloan Kettering Cancer Center, New York, NY
  Course Director
  Speaker
  
• Niaz Banaei, MD
  Associate Professor of Pathology and Medicine (Infectious Diseases)
  Stanford University School of Medicine
  Speaker
  
• Raj Behal, MD, MPH 
  Chief Quality Officer
  One Medical Group, San Francisco 
  Speaker
• Kristi Kuper, PharmD, BCPS
  Senior Clinical Manager of Infectious Disease
  Vizient Inc., Irving, TX 
  Speaker
  
• Anne Liu, MD
  Clinical Assistant Professor of Pediatrics - Immunology and Allergy
  Clinical Assistant Professor of Infectious Diseases
  Pediatric Allergy & Immunology Clinic
  Stanford University School of Medicine
  Speaker
  
• Preeti N. Malani, MD, MSJ, MS
  Professor of Infectious Diseases 
  University of Michigan Health System, Ann Arbor, MI
  Speaker
• Jason Newland, MD, MEd, FPIDS 
  Associate Professor of Pediatrics
  Washington University in St. Louis 
  Director of Antimicrobial Stewardship Program
  St. Louis Children’s Hospital, St. Louis, MO 
  Speaker
  
• Susan Seo, MD 
  Associate Professor of Clinical Medicine
  Weill Cornell Medical College 
  Director of Antibiotic Management Program
  Memorial Sloan Kettering Cancer Center, New York, NY 
  Speaker
• Edward A. Stenehjem, MD, MSc 
  Associate Professor of Medicine in the Division of Infectious Diseases
  Medical Director of Antimicrobial Stewardship
  Intermountain Medical Center, Salt Lake City, Utah 
  Speaker
  
• Kavita Trivedi, MD 
  Adjunct Clinical Assistant Professor
  Stanford University School of Medicine
  Founder
  Trivedi Consults LLC, Berkeley, CA
  Speaker
  
• Danilo Lo Fo Wong, PhD 
  Programme Manager Control of Antimicrobial Resistance Communicable Disease and Health Security 
  WHO Regional Office for Europe, Copenhagen, Denmark 
  Speaker
  
• The following planner and speakers have indicated that they have relationships with industry to disclose relative to the content of this activity.
• Thomas M File Jr., MD, MSc, MACP, FIDSA, FCCP
  Professor of Internal Medicine
  Northeastern Ohio Universities College of Medicine 
  Chief of the Infectious Disease Service and Director of HIV Research
  Summa Health System, Akron, OH 
  Speaker 
  Advisory Board Member: Allergan, Pfizer Inc., GlaxoSmithKline, The Medicine's Co., Merck, MotifBio 
  Consulting: Paratek, Shionogi Inc. 
• Conan MacDougall, PharmD, MAS, BCPS
  Professor of Clinical Pharmacy
  University of California San Francisco School of Pharmacy, SF, CA
  Speaker 
  Consulting: Shionogi Inc.
• Lina Meng, PharmD, BCPS, BCCP
  Antimicrobial Stewardship Pharmacist
  Stanford Hospital and Clinics
  Course Director
  Speaker 
  Ownership Interest: Gilead

Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.